The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Strong update, market seems to like it. Good to see us on the risers board.
It will be out Monday morning I would imagine
Are the reason behind the rise here this morning given the fan base
You beat me to it, just read my daily citywire email and saw the article. Good news and on the radar of a few more I would imagine. 450p price target
Does anybody have a view on whether a zotefoams product has been used in the process of these? Purely speculation but could this be the first result of the tie up? Be interested to get others thoughts https://hypebeast.com/2018/6/nike-react-element-87-first-release-info-official
Our acquisition programme, which includes seven completed deals in the last seventeen months, has created new complementary services, brands, products and customer sectors. Having made these significant enhancements, the Group will use 2018 as an opportunity to consolidate the processes and systems in place and start to exploit synergy opportunities in procurement, operations and back office, as well as continue to target organic growth... ... In summary, the Directors remain confident about the future; we fully expect our underlying performance to deliver another year of solid progress and we look forward to providing our next Trading Update for Q2 in early July."
Goes ex-dividend tomorrow
price / valuation looks reasonable so I am now a shareholder
They got the placing away with ease + for future growth and expansion, really looks a gem this one. Current trading Zotefoams has experienced a good start in the first four months of the year. Group revenue was approximately 7 per cent. ahead of the comparative period in 2017. However, after adjusting for the adverse impact of currency this year and excluding the large non-recurring capital contract invoiced by MuCell in the first quarter of 2017, Group revenue was approximately 17 per cent. ahead of last year. Underlying this strong performance were the following factors: � a 7 per cent. increase in sales of polyolefin foams; additional capacity has become available for the polyolefin foams business part-way through the period as the US facility began high-pressure gassing operations in March; � HPP foams experienced very strong growth, particularly from the PEBA product range, which accounted for approximately 50 per cent. of HPP revenue in the period; and � MuCell, excluding the large non-recurring capital contract invoiced in the first quarter of 2017, delivered a strong percentage increase in revenue against a relatively weak comparative in 2017. The Company's capital investment programmes are progressing on schedule: the US facility is now operating 24/7 and ramping up to full capacity; the investments to further extend high-pressure gassing in the US and to add high-temperature and low-pressure expansion in the UK remain on course for planned commissioning in 2019. Zotefoams continues to expect 2018 to be another year of substantial progress for the Group and, with committed capacity investments to support growth, it remains confident about the long-term prospects of the business.
Shame I missed the bounce here, near 50% in a month would have been nice. Hey ho
Anybody know when we�re getting the next trading update? Usually been mid May but can�t see it from recent rns. Expecting it to be good after comments made from the below Q&A: Q4: Is current trading performing to your expectations? A4: Yes, we started the first quarter, if we look at the order book in the first quarter, it�s really a continuation of what we saw in 2017; good volume growth, we see the high-performance business growing faster than the rest and we�re looking at mix and margin enhancement coming from that. So, a really good start in the first quarter. http://www.zotefoams.com/*************-qa-with-ceo-david-stirling/
Interested to see if IC will publicise an opinion on this deal given their recent tipping, iii also. It certainly changes the outlook here
http://www.thisismoney.co.uk/money/investing/article-5678603/Five-AIM-50-shares-worth-considering-theyre-going-cheap.html Iomart mentioned in here as one of the five aim 50 tips, probably the reason for the gains last week. Be good if the new buyers could push us over �4 this week